ALRN - .43891 Pre-market now at .535/.54 Aileron Therapeutics Announces the Initiation of Patient Treatment in its First Clinical Ph1b/2 Trial of ALRN-6924 as a Myelopreservation Agent https://www.tradescores.com/StockReport/alrn